Cite
Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review.
MLA
Minamiguchi, Kiyoyuki, et al. “Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI for Pretreatment Prediction of Efficacy-to-Standard-Therapies Based on Barcelona Clinic Liver Cancer Algorithm: An up-to-Date Review.” European Radiology, vol. 33, no. 12, Dec. 2023, pp. 8764–75. EBSCOhost, https://doi.org/10.1007/s00330-023-09950-0.
APA
Minamiguchi, K., Irizato, M., Uchiyama, T., Taiji, R., Nishiofuku, H., Marugami, N., & Tanaka, T. (2023). Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review. European Radiology, 33(12), 8764–8775. https://doi.org/10.1007/s00330-023-09950-0
Chicago
Minamiguchi, Kiyoyuki, Mariko Irizato, Tomoko Uchiyama, Ryosuke Taiji, Hideyuki Nishiofuku, Nagaaki Marugami, and Toshihiro Tanaka. 2023. “Hepatobiliary-Phase Gadolinium Ethoxybenzyl-Diethylenetriaminepentaacetic Acid MRI for Pretreatment Prediction of Efficacy-to-Standard-Therapies Based on Barcelona Clinic Liver Cancer Algorithm: An up-to-Date Review.” European Radiology 33 (12): 8764–75. doi:10.1007/s00330-023-09950-0.